Cantitate/Preț
Produs

Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact: Springer Theses

Autor Koki Yamamoto
en Limba Engleză Paperback – 24 ian 2021
This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact.
 
Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed.
 
The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure–activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist.
 
Demonstrating that it is possible to develop compounds that convert into their inactive forms under environmental conditions, this book is useful for anyone interested in therapeutic agents with reduced environmental impact.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 61269 lei  43-57 zile
  Springer Nature Singapore – 24 ian 2021 61269 lei  43-57 zile
Hardback (1) 61871 lei  43-57 zile
  Springer Nature Singapore – 24 ian 2020 61871 lei  43-57 zile

Din seria Springer Theses

Preț: 61269 lei

Preț vechi: 72080 lei
-15% Nou

Puncte Express: 919

Preț estimativ în valută:
11727 12222$ 9762£

Carte tipărită la comandă

Livrare economică 06-20 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811529672
ISBN-10: 9811529671
Ilustrații: XII, 86 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.15 kg
Ediția:1st ed. 2020
Editura: Springer Nature Singapore
Colecția Springer
Seria Springer Theses

Locul publicării:Singapore, Singapore

Cuprins

1. Introduction.- 2. Development of NK3R Antagonists with a Labile Functional Group in the Natural Environment.- 3. Development of NK3R Antagonists with a Degradable Scaffold in the Natural Environment: Synthesis and Application of Fused Piperazine Derivatives for Investigation of Degradable Core Motifs.- 4. Development of NK3R Antagonists with a Degradable Scaffold in the Natural Environment: Identification of NK3R Antagonists with a Decomposable Core Structure by Scaffold Hopping.- 5. Conclusion.

Recenzii




Textul de pe ultima copertă

This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact.
 
Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed.
 
The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure–activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist.
 
Demonstrating that it is possible to develop compounds that convert into their inactive forms under environmental conditions, this book is useful for anyone interested in therapeutic agents with reduced environmental impact.

Caracteristici

Nominated as an outstanding Ph.D. thesis by Kyoto University Presents a new concept of drug design to reduce environmental impact Shows how structure–activity studies help to design eco-friendly drugs